| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11029194 | Diabetes & Metabolic Syndrome: Clinical Research & Reviews | 2019 | 16 Pages |
Abstract
The beneficial effects of GLP-1RAs on HbA1c reached a plateau after the first year of treatment and are maintained at 4 years only in one third of patients. Failure occurred predominantly in men with a baseline HbA1c greater than 9%.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
A. Hemmer, D. Maiter, M. Buysschaert, V. Preumont,